Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.980
+0.030 (1.54%)
At close: Mar 6, 2026, 4:00 PM EST
1.950
-0.030 (-1.52%)
After-hours: Mar 6, 2026, 6:44 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $7.53 million as of March 6, 2026. Its market cap has increased by 35.95% in one year.
Market Cap
7.53M
Enterprise Value
3.08M
1-Year Change
35.95%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $7.53M, a decrease of -99.34%. That is a compound annual growth rate of -65.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.53M | 8.88% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.35M |
| PharmaCyte Biotech | 8.08M |
| Alaunos Therapeutics | 8.06M |
| KALA BIO | 7.86M |
| Ernexa Therapeutics | 7.72M |
| Pulmatrix | 7.45M |
| GridAI Technologies | 7.30M |
| Evogene | 7.27M |